Work by us and others has established that direct interactions with MSCs, rather than soluble molecules, drive changes in gene expression and metabolism that promote cancer stem-like cell states, resistance to anti-estrogen drugs, and metastasis in ER+ breast cancer (9–11). The gene discussed is ESR1; the disease is breast carcinoma.